TY  - JOUR

TI  - Compared to doxorubicin, might inhibit lymphocyte immunoglobulin autocrine loop and inflammation in the acute myeloid leukaemia cell line
JO  - Allergy and Clinical Immunology
PY  - 2026
DO  - 10.52338/aaci.2024.1004
ER  -